Cargando…
Comprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced Prostate Cancer: Differences in Genomic Landscape Based on Race
Advanced prostate cancer (aPC) in Black men was reported to present with aggressive features and to be associated with poor prognosis. Herein, we compared the cell-free DNA (cfDNA) genomic landscape of aPC in Black vs White men. Patients (pts) with aPC from 6 academic institutions and available cfDN...
Autores principales: | Zimmerman, Raquel, Bilen, Mehmet A, Heath, Elisabeth I, Nandagopal, Lakshminarayanan, Swami, Umang, Kessel, Adam, Jaeger, Ellen, Wesolowski, Sergiusz, Hernanadez, Edgar J, Chipman, Jonathan, Mack, Alleda, Ravindranathan, Deepak, Maughan, Benjamin L, Nussenzveig, Roberto, Yandell, Mark, Kohli, Manish, Lilly, Michael B, Sartor, A Oliver, Agarwal, Neeraj, Barata, Pedro C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526493/ https://www.ncbi.nlm.nih.gov/pubmed/36036607 http://dx.doi.org/10.1093/oncolo/oyac176 |
Ejemplares similares
-
Genomic landscape of advanced prostate cancer patients with BRCA1 versus BRCA2 mutations as detected by comprehensive genomic profiling of cell-free DNA
por: Swami, Umang, et al.
Publicado: (2022) -
Multi-institutional Analysis of the Clinical and Genomic Characteristics of Black Patients with Metastatic Hormone-Sensitive Prostate Cancer
por: Freeman, Meredith N, et al.
Publicado: (2022) -
Evolving Role of Immunotherapy in Metastatic Castration Refractory Prostate Cancer
por: Rathi, Nityam, et al.
Publicado: (2020) -
Mini-Review: Cabozantinib in the Treatment of Advanced Renal Cell Carcinoma and Hepatocellular Carcinoma
por: Rathi, Nityam, et al.
Publicado: (2020) -
The tango of immunotherapy and targeted therapy in metastatic renal cell carcinoma
por: Rathi, Nityam, et al.
Publicado: (2019)